We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+2.31%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$5.5B
AUM Growth
+$58M
Cap. Flow
-$11.2M
Cap. Flow %
-0.2%
Top 10 Hldgs %
36.95%
Holding
821
New
51
Increased
87
Reduced
185
Closed
82

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$25.4M
2
AMZN icon
Amazon
AMZN
+$17.1M
3
ROP icon
Roper Technologies
ROP
+$14.2M
4
TEL icon
TE Connectivity
TEL
+$12.1M
5
MSFT icon
Microsoft
MSFT
+$9.04M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$11.6M
2
TJX icon
TJX Companies
TJX
+$10.8M
3
JNJ icon
Johnson & Johnson
JNJ
+$8.91M
4
PG icon
Procter & Gamble
PG
+$8.9M
5
META icon
Meta Platforms (Facebook)
META
+$8.24M

Sector Composition

Rank Sector Weight
1 Technology 27.8%
2 Healthcare 17.78%
3 Financials 10.19%
4 Consumer Staples 9.56%
5 Consumer Discretionary 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIS icon
751
Fidelity National Information Services
FIS
$21.6B
– –
-99
Closed -$9K
FITB
752
Fifth Third Bancorp
FITB
$52.6B
$0 ﹤0.01%
29
– –
FNF icon
753
Fidelity National Financial
FNF
$12.8B
– –
-248
Closed -$9K
GFI icon
754
Gold Fields
GFI
$36.4B
– –
-2,500
Closed -$11K
B
755
Barrick Mining
B
$67.9B
– –
-700
Closed -$10K
HRL icon
756
Hormel Foods
HRL
$13.4B
$0 ﹤0.01%
19
– –
HUM icon
757
Humana
HUM
$46.7B
– –
-5
Closed -$1K
IART icon
758
Integra LifeSciences
IART
$1.35B
– –
-34
Closed -$2K
INGR icon
759
Ingredion
INGR
$6.54B
– –
-13
Closed -$2K
IQV icon
760
IQVIA
IQV
$39.8B
– –
-41
Closed -$4K
ITT icon
761
ITT
ITT
$19.4B
$0 ﹤0.01%
15
– –
JLL icon
762
Jones Lang LaSalle
JLL
$16.7B
– –
-7
Closed -$1K
KEYS icon
763
Keysight
KEYS
$60.6B
– –
-257
Closed -$11K
KN icon
764
Knowles
KN
$3.33B
– –
-239
Closed -$4K
KNX icon
765
Knight Transportation
KNX
$11.6B
– –
-30
Closed -$1K
LDOS icon
766
Leidos
LDOS
$17.6B
$0 ﹤0.01%
11
– –
LECO icon
767
Lincoln Electric
LECO
$15.6B
$0 ﹤0.01%
10
– –
LEG icon
768
Leggett & Platt
LEG
$1.29B
– –
-34
Closed -$2K
LHX icon
769
L3Harris
LHX
$54.1B
– –
-12
Closed -$2K
LII icon
770
Lennox International
LII
$14.5B
– –
-3
Closed –
LSTR icon
771
Landstar System
LSTR
$6.31B
– –
-15
Closed -$2K
LW icon
772
Lamb Weston
LW
$7.3B
– –
-893
Closed -$50K
MHK icon
773
Mohawk Industries
MHK
$9.27B
$0 ﹤0.01%
4
– –
MIDD icon
774
Middleby
MIDD
$5.38B
– –
-7
Closed –
MNKD icon
775
MannKind Corp
MNKD
$1.24B
$0 ﹤0.01%
80
– –
29 30
31
32 33

Similar funds

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Loring Wolcott & Coolidge Fiduciary Advisors held 821 positions worth $5.5B, up 1.1% from $5.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2018 filing shows 51 new, 87 increased, 185 reduced and 82 closed positions. Its largest new stake was Diamondback Energy: 3,285 shares worth $416K. The largest sale was Novo Nordisk, an estimated $11.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q1 2018 buy was Diamondback Energy: 3,285 shares worth $416K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Becton Dickinson in Q1 2018, an estimated $25.4M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q1 2018 reduction was Novo Nordisk, cutting an estimated $11.6M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $229K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 37% of its $5.5B portfolio in Q1 2018.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 51 new positions and closed 82 in Q1 2018.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 1.1% quarter-over-quarter to $5.5B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2018, filed 20 Apr 2018.